IRBESARTAN/HYDROCHLOROTHIAZIDE ZYDUS 300 mg/12,5 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949666911
  • CIP7 4966691
  • CIS 62840513

What the source publishes

Holder
ZYDUS FRANCE
Active ingredients
HYDROCHLOROTHIAZIDE, IRBÉSARTAN
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2010-10-29
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949666911
{
  "cis": "62840513",
  "cip7": "4966691",
  "form": "comprimé pelliculé",
  "name": "IRBESARTAN/HYDROCHLOROTHIAZIDE ZYDUS 300 mg/12,5 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400949666911",
  "holder": "ZYDUS FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "ZYDUS FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "4.66",
  "authorisedOn": "2010-10-29",
  "compositions": [
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "nature": "SA",
      "strength": "12,5 mg",
      "linkageNumber": "2",
      "substanceCode": "02064",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "IRBÉSARTAN",
      "nature": "SA",
      "strength": "300 mg",
      "linkageNumber": "1",
      "substanceCode": "31416",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.64",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "IRBESARTAN/HYDROCHLOROTHIAZIDE ZYDUS 300 mg/12,5 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2013-10-16",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "HYDROCHLOROTHIAZIDE",
    "IRBÉSARTAN"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949666911"